HOE 140
HOE 140 Basic information
- Product Name:
- HOE 140
- Synonyms:
-
- RRP-(HYP)-G-(THI)-S-(D-TIC)-(OIC)-R
- H-D-ARG-ARG-PRO-HYP-GLY-THI-SER-D-TIC-OIC-ARG-OH
- H2N-D-ARG-ARG-PRO-HYP-GLY-THI-SER-D-TIC-OIC-ARG-OH
- Icatibatide Acetate
- Icatibant
- D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin
- D-Arg-L-Arg-L-Pro-L-t4Hyp-Gly-L-Thi-L-Ser-D-Tic-L-Oic-L-Arg-OH
- H0E-140
- CAS:
- 130308-48-4
- MF:
- C59H89N19O13S
- MW:
- 1304.52
- Product Categories:
-
- peptide
- Mol File:
- 130308-48-4.mol
HOE 140 Chemical Properties
- Density
- 1.60±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- solubility
- Water:100.0(Max Conc. mg/mL);76.66(Max Conc. mM)
- pka
- 3.60±0.21(Predicted)
- form
- powder
- color
- white
- Water Solubility
- Soluble to 1 mg/ml in water
- Sequence
- H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH
- InChIKey
- QASONHYHOCRAHL-DOMVFXHKSA-N
- CAS DataBase Reference
- 130308-48-4
MSDS
- Language:English Provider:SigmaAldrich
HOE 140 Usage And Synthesis
Description
Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin), on bradykinin- and platelet-activating factor (PAF)-induced bronchoconstriction and airway microvascular leakage in anesthetized guinea pigs. Hoe 140 is highly potent and long-acting in inhibiting BK-induced hypotensive responses in the rat. Four hours after s.c. administration of 20nmol kg-1, inhibition still amounted to 60% whereas the effect of 200nmol kg-1 of d-Arg-[Hyp2, Thi5,8, d-Phe7]BK was not significant[1-2].
Uses
Antagonist (bradykinin).
Definition
ChEBI: A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acut attacks of hereditary angioedema in adult patients.
brand name
Metastat (CollaGenex).
storage
Store at -20°C
References
[1] K. Wirth. “Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.” British Journal of Pharmacology 102 3 (1991): 774–777.
[2] T Sakamoto. “Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.” European journal of pharmacology 213 3 (1992): 367–73.
HOE 140Supplier
- Tel
- 0512-58900862 400-0707518
- sales@alabiochem.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
HOE 140(130308-48-4)Related Product Information
- Efegatran
- N,N-DI-N-BUTYLETHYLENEDIAMINE
- 2-Amino-N-cyclohexylacetamide
- 1,2,3,4-Tetrahydroisoquinoline-3-carboxamide
- HOE 140
- 2-Aminoethyldiisopropylamine
- 1-ETHYL-3-PYRROLIDINOL
- HOE 140 SYNTHETIC >99% SELECTIVE B2 BRAD YKIN
- 1-METHYL-2-THIOPHEN-2-YL-ETHYLAMINE
- H-LEU-ARG-OH
- 3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YL)PROPAN-1-OL
- CHEMBRDG-BB 9070704
- METHYL-(2-THIOPHEN-2-YL-ETHYL)-AMINE
- 1-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-amine
- (3R)-1-(2-AMINOETHYL)-3-PYRROLIDINOL
- N-(2-(BENZYLAMINO)ETHYL) CYCLOHEXANAMINE
- (R)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID AMIDE
- N-formylmethamphetamine